USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Orbit Biomedical Limited

USPTO PatentsView assignee record - 12 granted patents across 7 technology areas, recorded in grant years 2018–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Orbit ranks #23,144 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 7 technology areas.

#23,144
of 49,997 US assignees by volume
28th percentile
by Innovation Score (28.6/100)
17.3
avg claims per patent
-50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R23144 · Foreign Corporation #23,144 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 12 grants
  • MID-PACK #23,144/49,997
  • PHOTO-FINISH Openfield
  • CPC-NARROW A61F · 7 areas
  • INNOV-THIN 28.6/100
  • CLAIMS-RICH 17.3 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -50% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Openfield (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Orbit’s 28.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Orbit

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Orbit's Innovation Score is 28.6/100 (28th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Orbit?

Each dot is one of Orbit’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Orbit’s own 17.3 claims/patent is ABOVE the 14.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Orbit vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 11.911.91212.1 010203040 Granted patents (volume) Avg claims / patent Openfield - 12, 18OpenfieldOpko Health, Inc. - 12, 13.5Opko HealthOpterna AM, Inc. - 12, 37.83Opterna AMOPW-Engineered Systems, Inc. - 12, 20.67Opw-engineered Sy…Otodata Wireless Network Inc. - 12, 9.42Otodata Wireless…Otsuka Techno Corporation - 12, 7.92Otsuka TechnoOtto Fuchs Kommanditgesellschaft - 12, 14.58Otto Fuchs Komman…Oxehealth Limited - 12, 15.83OxehealthOrbit Biomedical Limited - 12, 17.33Orbit Biomedical
Orbit vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Orbit's grants concentrate

Orbit Biomedical Limited is a focused PatentsView assignee: 7 CPC subclasses with 66.7% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2019 (7 grants) versus a trough of 1 in 2018. By volume, Orbit sits between Openfield and Oxehealth Limited.

Who files at Orbit's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Orbit holds 12 patents at rank #23,123, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Orbit

By rank, the assignees closest to #23,123 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Orbit's primary technology class.

Orbit's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

29 28th percentile higher than 28% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 201820192020 4
USPTO utility patent grants by year · 2018–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table
Orbit Biomedical Limited patent grants by year, 2015–2025
Year Patents Granted Share of Period
2018 1 8.3%
2019 7 58.3%
2020 4 33.3%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Orbit Biomedical Limited's patent record in context - here's where to go next.

  • Orbit Biomedical Limited's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 66.7% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #23,144 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Orbit Biomedical Limited against Openfield, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 28.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.